Home>>Biochemical Assay Reagents>>IPTG (Isopropyl β-D-thiogalactoside)

IPTG (Isopropyl β-D-thiogalactoside) (Synonyms: Isopropyl βthiogalactoside)

Catalog No.GC30002

IPTG (Isopropyl β-D-thiogalactoside) is a molecular mimic of allolactose, a lactose metabolite that triggers transcription of the lac operon, and it is therefore used to induce protein expression where the gene is under the control of the lac operator.

Products are for research use only. Not for human use. We do not sell to patients.

IPTG (Isopropyl β-D-thiogalactoside) Chemical Structure

Cas No.: 367-93-1

Size Price Stock Qty
10mM (in 1mL DMSO)
$50.00
In stock
1g
$46.00
In stock
5g
$73.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 3 publications

Description Chemical Properties Product Documents Related Products

IPTG is a molecular mimic of allolactose, a lactose metabolite that triggers transcription of the lac operon, and it is therefore used to induce protein expression where the gene is under the control of the lac operator.

IPTG uptake by E. coli can be independent of the action of lactose permease, since other transport pathways are also involved. At low concentration, IPTG enters cells through lactose permease, but at high concentrations (typically used for protein induction), IPTG can enter the cells independently of lactose permease[1].

[1]. Isopropyl β-D-1-thiogalactopyranoside

Reviews

Review for IPTG (Isopropyl β-D-thiogalactoside)

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for IPTG (Isopropyl β-D-thiogalactoside)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.